BHC
$31.42
Bausch Health Companies
$.14
.45%
BHC
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  $0.95
Revenue:  $2.06 Bil
Wednesday
May 26
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made Wednesday, February 24, 2021

What do you expect when BHC reports earnings?
Beat
Meet
Miss

Where is BHC's stock price going from here?
Up
Flat
Down
Stock chart of BHC
Analysts
Summary of analysts' recommendations for BHC
Score
Grade
Pivots
Resistance
$33.23
$32.55
$31.99

$31.31

Support
$30.74
$30.06
$29.50
Tweet
Growth
Description
Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is based in NJ, United States.